Digilab has a rich history of technology and applications
market leadership in spectrometry and photonics spanning over the past 40
In September of 2004, Digilab sold its product
assets to Varian Inc., Digilab, Inc invested the proceeds of this transaction
in a business model focused principally on life science research tools and
downstream point of need clinical, safety and security applications.
In June of 2006, Digilab acquired SpectraCode Inc. in West Lafayette, Indiana. This acquisition
provides Digilab core competence and products in high growth applications which
require the versatility and ease of use of Raman Molecular Spectroscopy
In November of 2007, Digilab
acquired Genomic Solutions (which included Gene Machines, Cartesian, and
BioRobotics) and MAIA Scientific.
From these acquisitions, Digilab provides innovative,
value-added solutions for scientific research and discovery in Life Science,
Analytical Chemistry and Clinical and Diagnostic markets. Digilab’s products
and technologies includes a wide range of sample preparation tools for DNA
shearing and DNA sequencing sample preparation, custom protein and DNA
microarrays, protein sample preparation for High Performance Liquid
Chromatography (HPLC) and Mass
Spectrometry (MS),oligonucleotide synthesis, live cell printing
and dispensing, hybridization, and general liquid handling.
Digilab also provides tools and technologies for sample
identification which include imaging and image analysis products for cell
research and High Content Analysis (HCA)
applications, and Raman spectroscopy-based products for customers for a wide
range of applications and markets.
Digilab, via a series of acquisitions and partnerships, is
implementing this business model. Its vision and strategy is
retention/expansion of market awareness as a company with unique and high value
products for principally the health sciences markets.